Coronavirus (COVID-19) – Use of Paxlovid (nirmatrelvir + ritonavir) in residential aged care

This fact sheet outlines the key considerations of introducing Paxlovid® (nirmatrelvir + ritonavir) into residential aged care clinical practices.


Coronavirus (COVID-19) – Use of Paxlovid® (nirmatrelvir + ritonavir) in residential aged care

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Publication type:
Fact sheet
Health sector

Help us improve

If you would like a response please use the enquiries form instead.